BCMALL
0187
PERMAJU-PA
7080PA
EAH
0154
KGROUP
0036
NOVAMSC-PA
0026PA
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|
Total revenue | -2.12%33.04M | 37.09%33.75M | 19.05%24.62M | -28.30%20.68M | 4.5M | 7.17M | 3.31%28.84M | 27.92M |
Cost of revenue | -2.42%26.96M | 38.08%27.63M | 23.74%20.01M | -25.43%16.17M | 3.67M | 5.45M | 1.24%21.68M | 21.42M |
Gross profit | -0.75%6.08M | 32.81%6.13M | 2.24%4.61M | -36.99%4.51M | 831.68K | 1.73M | 10.14%7.16M | 6.5M |
Operating expense | -0.99%3.27M | -18.00%3.3M | 54.61%4.03M | -22.13%2.61M | 666.74K | 639K | -8.26%3.35M | 3.65M |
Selling and administrative expenses | ---- | ---- | ---- | ---- | ---- | --70K | -17.85%1.03M | --1.25M |
-Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | --70K | -17.85%1.03M | --1.25M |
Other operating expenses | -0.99%3.27M | -18.00%3.3M | 54.61%4.03M | 12.47%2.61M | --965.74K | --569K | -3.24%2.32M | --2.39M |
Operating profit | -0.46%2.81M | 383.24%2.82M | -69.35%584.12K | -50.03%1.91M | 164.94K | 1.09M | 33.65%3.81M | 2.85M |
Net non-operating interest income (expenses) | -170.70%-154.59K | -17.72%-57.11K | 28.45%-48.51K | 62.86%-67.8K | 37.21K | -56K | 28.30%-182.52K | -254.55K |
Non-operating interest income | 104.97%188.52K | 41.82%91.98K | -34.02%64.86K | 558.24%98.3K | ---- | ---- | -66.68%14.93K | --44.82K |
Non-operating interest expense | 130.15%343.12K | 31.51%149.08K | -31.75%113.37K | -15.88%166.1K | --61.1K | --56K | -34.04%197.45K | --299.36K |
Net investment income | 511.49K | |||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||
Income from associates and other participating interests | ||||||||
Special income (charges) | 0 | -85.03%1.45K | -96.97%9.7K | 35.75%320.04K | 25.23%235.76K | 188.26K | ||
Less:Other special charges | ---- | ---1.45K | ---- | -256.62%-110.02K | ---- | ---- | 83.61%-30.85K | ---188.26K |
Less:Write off | ---- | ---- | 95.38%-9.7K | -2.49%-210.02K | ---- | ---- | ---204.91K | --0 |
Other non-operating income (expenses) | 19.84%38.05K | 101.59%31.75K | -85.06%15.75K | 91.64%105.45K | -345.55K | 396K | -58.25%55.03K | 131.81K |
Income before tax | -3.77%2.69M | 398.84%2.8M | -75.21%561.06K | -48.95%2.26M | 176.63K | 1.43M | 51.89%4.43M | 2.92M |
Income tax | 0.86%844.97K | 67.53%837.73K | 7.33%500.04K | -65.81%465.87K | 18.87K | 289K | 43.67%1.36M | 948.4K |
Net income | -5.76%1.85M | 3,113.82%1.96M | -96.61%61.02K | -41.46%1.8M | 157.76K | 1.14M | 55.84%3.07M | 1.97M |
Net income continuous operations | -5.76%1.85M | 3,113.82%1.96M | -96.61%61.02K | -41.46%1.8M | --157.76K | --1.14M | 55.84%3.07M | --1.97M |
Noncontrolling interests | 0 | 0 | 0 | 143.02%37.18K | -86.43K | |||
Net income attributable to the company | -5.76%1.85M | 3,113.82%1.96M | -96.61%61.02K | -40.75%1.8M | 157.76K | 1.14M | 47.48%3.03M | 2.06M |
Preferred stock dividends | ||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -5.76%1.85M | 3,113.82%1.96M | -96.61%61.02K | -40.75%1.8M | 157.76K | 1.14M | 47.48%3.03M | 2.06M |
Gross dividend payment | ||||||||
Basic earnings per share | -6.78%0.0055 | 2,850.00%0.0059 | -96.67%0.0002 | -34.07%0.006 | 0.0011 | 0.0032 | 47.49%0.0091 | 0.0062 |
Diluted earnings per share | -6.78%0.0055 | 3,055.08%0.0059 | -96.88%0.0002 | -34.07%0.006 | 0.0005 | 0.0028 | 47.49%0.0091 | 0.0062 |
Dividend per share | 0.00%0.0015 | 0.00%0.0015 | 0.0015 | |||||
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.